Role of the intestinal flora in the metabolism of misonidazole |
| |
Authors: | Ronald L. Koch Bernard B. Beaulieu Peter Goldman |
| |
Affiliation: | Division of Clinical Pharmacology, Department of Pharmacology, Harvard Medical School, Beth Israel Hospital, Boston, MA 02215, U.S.A. |
| |
Abstract: | The radiation sensitizer misonidazole is metabolized to its amino derivative [1-(2-aminoimidazol-1-yl)-3-methoxypropan-2-o1] in pure or mixed cultures of the intestinal microflora. This metabolite appears in the excreta of conventional rats but is not detectable in the excreta of germfree rats. Thus. its formation appears to be due to the activity of the intestinal flora in vivo as well as in vitro. CO2 is liberated from 1(2aminoimidazol1yl)3methoxypropan2o1 by pure and mixed cultures of the In cultures of Clostridium perfringens that lack urease, the release of CO2 depends on added urease, suggesting that urea is an intermediate in this pathway. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|